2014-2018 World Papillomavirus Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-- US, Europe (France, Germany, Italy, Spain, UK), Japan
The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
I. INTRODUCTION
II. HPV/PAPILLOMAVIRUS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: Pap Smear and HPV
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
II. HPV/PAPILLOMAVIRUS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: Pap Smear and HPV
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Ortho-Clinical Diagnostics/J&J
- Kreatech
- Life Technologies
- Lonza
- Nanogen/Elitech
- Novartis
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wako
LIST OF TABLES
France: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Contains 191 pages and 14 tables
France: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Contains 191 pages and 14 tables